Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of flutamide (Drogenil) in pancreatic carcinoma
ISRCTN75847548Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 1995
- Modality
- Small Molecules
01
Overview
Phase 3 trial of flutamide in pancreatic cancer (PC) (2 arms), sponsored by Merck & Co. Started Jan 1995; status: completed.
02
Drugs
flutamide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ISRCTN75847548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75847548.